China National Accord Medicines Corp. Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE0000009N6
  • SHE: 000028
CNY
19.90
-0.13 (-0.65%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
18,442.95
17,823.41
18,291.37
18,327.89
18,503.08
18,293.52
17,912.14
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
18,442.95
17,823.41
18,291.37
18,327.89
18,503.08
18,293.52
17,912.14
Raw Material Cost
16,877.73
16,350.48
16,526.05
16,774.95
16,824.20
16,761.61
16,225.06
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
36.85
33.33
63.18
40.22
47.47
43.63
59.75
Selling and Distribution Expenses
1,054.72
1,086.90
1,245.74
1,109.64
1,176.61
1,095.31
1,351.32
Other Expenses
-3.53
-3.22
-6.02
-3.58
-4.22
-3.82
-5.49
Total Expenditure (Excl Depreciation)
17,934.03
17,438.51
17,774.75
17,889.05
18,006.04
17,862.37
17,581.22
Operating Profit (PBDIT) excl Other Income
508.9
384.90000000000003
516.5999999999999
438.8
497
431.1
330.90000000000003
Other Income
-14.94
2.96
-15.92
-5.66
2.03
-2.91
-56.15
Operating Profit (PBDIT)
767.68
667.54
716.26
683.53
866.97
801.21
-317.86
Interest
36.85
33.33
63.18
40.22
47.47
43.63
59.75
Exceptional Items
-7.06
0.00
-254.02
3.23
0.00
0.00
-23.82
Gross Profit (PBDT)
1,565.21
1,472.93
1,765.32
1,552.94
1,678.88
1,531.91
1,687.08
Depreciation
327.48
327.48
295.21
295.21
419.47
419.47
438.83
Profit Before Tax
396.29
306.73
103.86
351.34
400.03
338.11
-840.26
Tax
107.89
71.70
82.41
92.74
114.87
90.65
77.67
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
318.74
287.46
178.81
291.21
337.91
328.00
-423.05
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
318.74
287.46
178.81
291.21
337.91
328.00
-423.05
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
23.90
17.70
-69.86
15.59
27.01
19.68
-435.62
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
342.64
305.16
108.95
306.80
364.92
347.68
-858.67
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
18,873.32
18,897.43
18,609.96
18,429.95
18,136.17
17,997.53
17,669.53
Earnings per share (EPS)
0.52
0.47
0.29
0.48
0.55
0.54
-0.69
Diluted Earnings per share
0.52
0.47
0.29
0.48
0.55
0.54
-0.69
Operating Profit Margin (Excl OI)
2.47%
1.89%
2.39%
2.15%
2.41%
2.1%
-3.91%
Gross Profit Margin
3.92%
3.56%
2.18%
3.53%
4.43%
4.14%
-2.24%
PAT Margin
1.73%
1.61%
0.98%
1.59%
1.83%
1.79%
-2.36%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2026 is 3.48% vs -2.56% in Mar 2026

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2026 is 12.25% vs 180.00% in Mar 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2026 is 17.76% vs -9.23% in Mar 2026

stock-summary

Interest

QoQ Growth in quarter ended Jun 2026 is 10.81% vs -47.31% in Mar 2026

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

Compare Quarterly Results Of China National Accord Medicines Corp. Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
18,442.95
0
18,442.95
Other Operating Income
0.00
0.00
0.00
Total Operating income
18,442.95
0
18,442.95
Raw Material Cost
16,877.73
0
16,877.73
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
36.85
0
36.85
Selling and Distribution Expenses
1,054.72
0
1,054.72
Other Expenses
-3.53
0.00
-3.53
Total Expenditure (Excl Depreciation)
17,934.03
0
17,934.03
Operating Profit (PBDIT) excl Other Income
508.91
0.00
508.91
Other Income
-14.94
0
-14.94
Operating Profit (PBDIT)
767.68
0
767.68
Interest
36.85
0
36.85
Exceptional Items
-7.06
0
-7.06
Gross Profit (PBDT)
1,565.21
0
1,565.21
Depreciation
327.48
0
327.48
Profit Before Tax
396.29
0
396.29
Tax
107.89
0
107.89
Provisions and contingencies
0
0
0.00
Profit After Tax
318.74
0
318.74
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
318.74
0
318.74
Share in Profit of Associates
0
0
0.00
Minority Interest
23.90
0
23.90
Other related items
0.00
0.00
0.00
Consolidated Net Profit
342.64
0
342.64
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
18,873.32
0
18,873.32
Earnings per share (EPS)
0.52
0
0.52
Diluted Earnings per share
0.52
0
0.52
Operating Profit Margin (Excl OI)
2.47%
0%
0.00
2.47%
Gross Profit Margin
3.92%
0%
0.00
3.92%
PAT Margin
1.73%
0%
0.00
1.73%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1,844.29 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 3.48% vs -2.56% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is -0.33% vs -1.03% in Jun 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 34.26 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 12.25% vs 180.00% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is -6.11% vs 12.66% in Jun 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 78.26 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 17.76% vs -9.23% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is -9.52% vs 6.33% in Jun 2025

Quarterly - Interest
Interest 3.69 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 10.81% vs -47.31% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is -22.32% vs -37.75% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 2.47%
in Jun 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025

Footer loading